Sponsor Pipeline

Gritbio Medicine, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-14 NCT07766317 Autologous Tumor Infiltrating Lymphocyte (TIL) GT201 Infusion. Phase 1/2 Not Yet Recruiting
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07766317 Autologous Tumor Infiltrating Lymphocyte (TIL) GT201 Infusion. Advanced Solid Tumors Cancer Not Yet Recruiting
Get alerts when Gritbio Medicine, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free